臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 501-525 of 1656 (67 Page(s) Totally)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-15T07:44:43Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.;Liu T.-H.;Hsu C.;Li-Chun Lu;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; Shao Y.-Y.; Liu T.-H.; Hsu C.; LI-CHUN LU; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-15T07:44:43Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Li-Chun Lu;Hsu C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.; LI-CHUN LU; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:42Z	Solving the deficit of cancer pain management skills by education programs	Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; LI-CHUN LU; Hsu C.-H.
臺大學術典藏	2021-03-15T06:27:34Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; DWANG-YING CHANG; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.
臺大學術典藏	2021-03-11T04:29:16Z	Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus	Chia Y.M.F.;Teng T.-H.K.;Tay W.T.;Anand I.;Macdonald M.R.;Yap J.;Chandramouli C.;Richards A.M.;Tromp J.;Ouwerkerk W.;Ling L.H.;Lam C.S.P.;Hung C.-L.;Liew H.B.;Narasimhan C.;Ngarmukos T.;Park S.W.;Reyes E.;Siswanto B.B.;Shimizu W.;Zhang S.;Fan X.;Chen K.;Wu L.;Xie Y.;Jin Q.;Ling T.;Li X.;Zhou F.;Zhou Y.;Xu D.;Zhang H.;Su Y.;Chen X.;Qin S.;Wang J.;Gong X.;Wu Z.;Yu C.M.;Sastry B.K.S.;Gopi A.;Raghu K.;Sridevi C.;Kaur D.;Naik A.;Parikh K.;Chandarana A.;Shah U.;Chag M.;Baxi H.;Gupta S.;Bhatia J.;Khakhkhar V.;Sankhla V.;Patel T.;Kapoor V.;Wander G.S.;Tandon R.;Chopra V.;Kumar M.;Sethi H.J.S.;Verma R.;Mittal S.;Sawhney J.;Sharma M.K.;Purayil M.P.;Tedjokusumo P.;Martanto E.;Erwinanto, Munawar M.;Pambudi J.A.;Lukito A.;Pardede I.;Thengker A.;Damay V.;Danny S.S.;Surarso R.;Noda T.;Nakajima I.;Wada M.;Ishibashi K.;Kurita T.;Yasuoka R.;Asai K.;Murai K.;Kubota Y.;Izumi Y.;Ikeda T.;Hisatake S.;Kabuki T.;Kiuchi S.;Hagiwara N.;Suzuki A.;Suzuki T.;Hong S.K.;Lee S.;Soo L.D.;Kim D.-H.;Shim J.;Park S.-M.;Roh S.-Y.;Kim Y.H.;Kim M.;Choi J.-I.;Na J.O.;Rha S.W.;Seo H.S.;Oh D.J.;Park C.G.;Kim E.J.;Joung B.;Uhm J.-S.;Lee M.H.;Cho I.-J.;Park H.-N.;Park H.-W.;Cho J.-G.;Yoon N.;Lee K.;Kim K.H.;Kim S.H.;Saharudin S.;Beh B.C.;Lee Y.W.;Yen C.H.;Othman M.K.;Augustine A.-A.;Asnawi M.H.M.;Mojolou R.A.;Tan Y.Z.;Arbain A.N.;Wong C.K.;Omar R.;Ghazi A.M.;Khelae S.K.;Chew D.S.P.;Yap L.B.;Hussin A.;Muhammad Z.;Azmee M.G.;Abidin I.Z.;Zhudi A.S.B.M.;Sari N.A.M.;Sridhar G.S.;Zuhdi A.S.M.;Ismail M.D.;Ong T.K.;Cham Y.L.;Khiew N.Z.;Said A.B.;Fong A.Y.Y.;Amin N.H.M.;Seng K.C.;Tan S.K.;Yew K.L.;Santos J.;Lim A.;Lapitan R.;Andal R.;Lopez E.;Sim K.L.D.;Tan B.Y.;Lim C.P.;Teo L.L.Y.;Chan L.L.H.;Chai P.;Wong C.C.R.;Poh K.K.;Yeo P.S.D.;Lee E.M.;Loh S.Y.;Ching M.E.;Khoo D.Z.L.;Yew M.S.;Huang W.;Leong K.T.G.;See J.H.J.;Lim Y.B.;Tan S.;Yeo C.;Chai S.C.;Jaufeerally F.R.;Tulsidas H.;Aung T.;Ong H.Y.;Ling L.F.;Soon D.K.N.;Yeh H.-I.;Kuo J.-Y.;Yen C.-H.;Hwang J.-J.;Chien K.-L.;Su T.-C.;Lin L.-Y.;Juang J.-M.;Lin Y.-H.;Fu-Tien Chiang;Lin J.-L.;Ho Y.-L.;Lee C.-M.;Lin P.-C.;Hung C.-S.;Chang S.-N.;Lin J.-W.;Hsu C.-N.;Yu W.-C.;Chao T.-F.;Sung S.-H.;Wang K.-L.;Leu H.-B.;Lin Y.-J.;Chang S.-L.;Huang P.-H.;Lo L.-W.;Wu C.-H.;Liang H.-Y.;Chang S.-S.;Hsiao L.-C.;Wang Y.-C.;Lu C.-R.;Wu H.-P.;Lin Y.-N.;Chen K.-W.;Lo P.-H.;Hsu C.-H.;Hsieh L.-C.;Chandavimol M.;Yingchoncharoen T.;Laothavorn P.;Tiyanon W.;Wongcharoen W.;Phrommintikul A.;On Behalf Of The Asian-Hf Investigators; Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Lam C.S.P.; Hung C.-L.; Liew H.B.; Narasimhan C.; Ngarmukos T.; Park S.W.; Reyes E.; Siswanto B.B.; Shimizu W.; Zhang S.; Fan X.; Chen K.; Wu L.; Xie Y.; Jin Q.; Ling T.; Li X.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Yu C.M.; Sastry B.K.S.; Gopi A.; Raghu K.; Sridevi C.; Kaur D.; Naik A.; Parikh K.; Chandarana A.; Shah U.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Tandon R.; Chopra V.; Kumar M.; Sethi H.J.S.; Verma R.; Mittal S.; Sawhney J.; Sharma M.K.; Purayil M.P.; Tedjokusumo P.; Martanto E.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Danny S.S.; Surarso R.; Noda T.; Nakajima I.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Kabuki T.; Kiuchi S.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Park S.-M.; Roh S.-Y.; Kim Y.H.; Kim M.; Choi J.-I.; Na J.O.; Rha S.W.; Seo H.S.; Oh D.J.; Park C.G.; Kim E.J.; Joung B.; Uhm J.-S.; Lee M.H.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Saharudin S.; Beh B.C.; Lee Y.W.; Yen C.H.; Othman M.K.; Augustine A.-A.; Asnawi M.H.M.; Mojolou R.A.; Tan Y.Z.; Arbain A.N.; Wong C.K.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Azmee M.G.; Abidin I.Z.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Amin N.H.M.; Seng K.C.; Tan S.K.; Yew K.L.; Santos J.; Lim A.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Tan B.Y.; Lim C.P.; Teo L.L.Y.; Chan L.L.H.; Chai P.; Wong C.C.R.; Poh K.K.; Yeo P.S.D.; Lee E.M.; Loh S.Y.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Jaufeerally F.R.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Chien K.-L.; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; FU-TIEN CHIANG; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Hung C.-S.; Chang S.-N.; Lin J.-W.; Hsu C.-N.; Yu W.-C.; Chao T.-F.; Sung S.-H.; Wang K.-L.; Leu H.-B.; Lin Y.-J.; Chang S.-L.; Huang P.-H.; Lo L.-W.; Wu C.-H.; Liang H.-Y.; Chang S.-S.; Hsiao L.-C.; Wang Y.-C.; Lu C.-R.; Wu H.-P.; Lin Y.-N.; Chen K.-W.; Lo P.-H.; Hsu C.-H.; Hsieh L.-C.; Chandavimol M.; Yingchoncharoen T.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators
臺大學術典藏	2021-03-10T05:34:20Z	Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation	Ta-Chen Huang; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-10T05:34:20Z	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Ta-Chen Huang; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L.
臺大學術典藏	2021-03-10T05:34:19Z	Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer	Ta-Chen Huang; Hsu C.-H.; Lin C.-C.; Tu Y.-K.
臺大學術典藏	2021-03-10T05:34:19Z	Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy	Chen W.-W.; Lin C.-C.; Ta-Chen Huang; Cheng A.-L.; Yeh K.-H.; Hsu C.-H.
臺大學術典藏	2021-03-10T05:34:19Z	Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma	Guo J.-C.; Ta-Chen Huang; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2021-03-10T05:34:18Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	Guo J.-C.; Lin C.-C.; Ta-Chen Huang; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M.
臺大學術典藏	2021-03-10T05:34:18Z	On predicting clinical response to chemoradiotherapy in esophageal squamous cell carcinoma: Additional evaluation by magnetic resonance imaging may help	Ta-Chen Huang; Hsu C.-H.
臺大學術典藏	2021-03-10T05:34:17Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Ta-Chen Huang; Hsu C.-H.
臺大學術典藏	2021-03-10T05:34:17Z	Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma	Ta-Chen Huang; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H.
臺大學術典藏	2021-03-09T06:46:18Z	A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers	Yeh K.-H.;Cheng A.-L.;Lin M.-T.;Ruey-Long Hong;Hsu C.-H.;Lin J.-F.;Chang K.-J.;Lee P.-H.;Chen Y.-C.; Yeh K.-H.; Cheng A.-L.; Lin M.-T.; RUEY-LONG HONG; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C.
臺大學術典藏	2021-03-09T06:46:15Z	Prognostic value of multidrug resistance 1, glutathione-S-transferase-�k and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy	Hsu C.-H.;Chen C.-L.;Ruey-Long Hong;Chen K.-L.;Lin J.-F.;Cheng A.-L.; Hsu C.-H.; Chen C.-L.; RUEY-LONG HONG; Chen K.-L.; Lin J.-F.; Cheng A.-L.
臺大學術典藏	2021-03-09T06:46:06Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; RUEY-LONG HONG; Hsu C.-H.; Chengb A.-L.
臺大學術典藏	2021-03-09T05:18:40Z	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract	Hsu C.; Ying-Chun Shen; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:37Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Ying-Chun Shen; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:36Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:35Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Hsu C.-Y.; Ying-Chun Shen; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2021-03-09T05:18:34Z	High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy	Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:33Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shao Y.-Y.; Lu L.-C.; Lin Z.-Z.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:31Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:31Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Ying-Chun Shen; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.

Showing items 501-525 of 1656 (67 Page(s) Totally)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2823024
	???header.visitor??? : 30271194 ???header.onlineuser??? : 695 ???header.sponsordeclaration???